In summary, our experiment showed that chemokine CXCL3 is highly expressed in COAD, and its high-level expression is closely associated with several tumor-associated clinicopathological parameters, chemokines, genes, signaling pathways and immunocyte recruitment. This evidence concerns the gene CXCL3 and neoplasm.